ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 93 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 3.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,100,000 | -8.3% | 647,008 | +11.1% | 0.01% | 0.0% |
| Q1 2022 | $1,200,000 | -43.4% | 582,508 | +3.1% | 0.01% | -37.5% |
| Q4 2021 | $2,120,000 | +438.1% | 565,208 | +640.8% | 0.01% | +300.0% |
| Q3 2021 | $394,000 | -95.5% | 76,300 | -96.3% | 0.00% | -94.9% |
| Q2 2021 | $8,772,000 | -16.5% | 2,059,092 | +4.1% | 0.04% | -20.4% |
| Q1 2021 | $10,504,000 | +11.4% | 1,978,234 | +13.0% | 0.05% | +6.5% |
| Q4 2020 | $9,433,000 | +131.9% | 1,750,000 | +483.3% | 0.05% | +170.6% |
| Q3 2018 | $4,068,000 | +528.7% | 300,000 | +209.6% | 0.02% | +466.7% |
| Q4 2017 | $647,000 | -73.6% | 96,900 | -82.2% | 0.00% | -78.6% |
| Q2 2017 | $2,449,000 | -15.1% | 545,500 | +4.2% | 0.01% | -12.5% |
| Q1 2017 | $2,883,000 | +83.6% | 523,300 | +301.9% | 0.02% | +23.1% |
| Q4 2015 | $1,570,000 | – | 130,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |